Variant report

Variant	rs10734819
Chromosome Location	chr12:10358206-10358207
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 13 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:11)

rs_ID	r²[population]
rs10734820	0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs10772239	0.83[ASN][1000 genomes]
rs10772240	0.83[ASN][1000 genomes]
rs10772241	1.00[ASN][1000 genomes]
rs10772242	0.81[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs10845065	0.83[ASN][1000 genomes]
rs10845066	0.86[ASN][1000 genomes]
rs10845068	0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs11053674	0.82[ASN][1000 genomes]
rs4763462	0.89[AFR][1000 genomes];0.99[ASN][1000 genomes]
rs9971725	0.89[AFR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv898757	chr12:10229281-10614641	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Genic enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	48 gene(s)	inside rSNPs	diseases
2	nsv1054811	chr12:10350587-10440005	Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:23 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:10357200-10358800	Enhancers	Hela-S3	cervix
2	chr12:10357200-10359200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
3	chr12:10357400-10358400	Enhancers	H9 Cell Line	embryonic stem cell
4	chr12:10357400-10358400	Enhancers	HMEC	breast
5	chr12:10357400-10358600	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr12:10357400-10358800	Enhancers	HUES6 Cell Line	embryonic stem cell
7	chr12:10357400-10358800	Enhancers	iPS-15b Cell Line	embryonic stem cell
8	chr12:10357400-10358800	Enhancers	NHEK	skin
9	chr12:10357400-10359000	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr12:10357400-10359000	Enhancers	Placenta	Placenta
11	chr12:10357600-10358600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
12	chr12:10357600-10358600	Enhancers	Muscle Satellite Cultured Cells	--
13	chr12:10357600-10358600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr12:10357600-10358800	Enhancers	iPS-20b Cell Line	embryonic stem cell
15	chr12:10357600-10358800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr12:10357800-10358600	Enhancers	iPS-18 Cell Line	embryonic stem cell
17	chr12:10358000-10358400	Enhancers	HUES64 Cell Line	embryonic stem cell
18	chr12:10358000-10358400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
19	chr12:10358000-10358400	Enhancers	NH-A	brain
20	chr12:10358000-10358400	Enhancers	Osteobl	bone
21	chr12:10358000-10358800	Enhancers	Placenta Amnion	Placenta Amnion
22	chr12:10358200-10364600	Weak transcription	H1 Cell Line	embryonic stem cell
23	chr12:10358200-10364600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links